Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Current smoking in GD is linked to higher TRAb levels, increased odds of orbitopathy, and higher 12-month relapse risk after drug withdrawal.

When fresh data appeared in the British Medical Journal in early 2026, it confirmed a suspicion that physicians had long harbored. Patients who discontinue ...

Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...

Worldwide rights position Erasca to advance ERAS-0015 through a unified global development strategyERAS-0015’s promising early clinical data ...